Login to Your Account



China’s Bio Poster Boy Aims to Boost Drug Development via Converd

By Shannon Ellis
Staff Writer

Monday, September 16, 2013

SHANGHAI – Hu Fang was the poster boy for China’s potential in biomedicine back in 2005. At the head of Shanghai Sunway Biotech Co. Ltd., he saw the need to bring innovative drug development to China and found a truly entrepreneurial method to do it: Take a molecule patented in the U.S. that had been gathering dust after an aborted early stage clinical trial and develop it for the China market.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription